Bill co-sponsored by Rep. Kim empowers Medicare to negotiate lower drug prices and would save Americans at least $345 billion
Last week, the House passed a bold, bipartisan bill to bring down the cost of prescription drugs. Rep. Andy Kim championed the “Elijah Eugene Cummings Lower Drug Prices Now Act” (H.R. 3), which allows Medicare to negotiate with drug companies for lower prescription drug prices and reverse unjustified price gouging on thousands of medications like insulin.
And while Rep. Kim is keeping his promise to put the American people first, Republican candidates like John Novak and Kate Gibbs have been silent on this critical issue.
Now that the vote has been cast, these Republican candidates must go on the record and make it clear where they stand. Are Novak and Gibbs for lining the pockets of big drug manufacturers or for lowering prescription drug costs for Ocean and Burlington County families?
“There is no question that seniors and working families desperately need relief from out of control drug prices. John Novak and Kate Gibbs’ lack of transparency signals they’re willing to put big drug and insurance companies first,” said DCCC Spokesperson Christine Bennett. “Leaders lead and if either one of these candidates wants to have any shot of convincing New Jerseyans that they would be different, they need to speak out in support of common-sense solutions Rep. Kim has been leading on.”
###